RT Book, Section
A1 Fitzpatrick, Meghan E.
A1 Prendergast, Niall T.
A1 Rivera-Lebron, Belinda
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1186013080
T1 Alveolar Hemorrhage Syndromes
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1186013080
RD 2024/04/19
AB Diffuse  alveolar  hemorrhage  may  occur  in  a  variety  of  immune  and  nonimmune  disorders.  Alveolar  infiltrates  on  chest  radiograph,  dyspnea,  anemia,  hemoptysis  and,  occasionally,  fever  are  characteristic.  Rapid  clearing  of  diffuse  lung  infiltrates  within  2  days  is  a  clue  to  the  diagnosis  of  diffuse  alveolar  hemorrhage  (eFigure  9–25).  Pulmonary  hemorrhage  can  be  associated  with  an  increased  single-breath  diffusing  capacity  for  carbon  monoxide  (DLCO),  although  this  test  is  infrequently  obtained.  Sequential  BAL  on  bronchoscopy  is  the  preferred  method  for  diagnosis.  Diffuse  alveolar  hemorrhage  is  confirmed  when  lavage  aliquots  are  progressively  more  hemorrhagic.